BroadOak Capital Partners, with headquarters in Washington, DC, and San Francisco, is a life-sciences focused boutique financial institution that provides direct investment and investment banking services to companies in research tools and consumables, diagnostics, biopharma services, and adjacent markets. BroadOak has led or participated in investments in more than fifty companies across multiple funds and investment vehicles.
Location: United States, California, Brisbane
Employees: 11-50
Founded date: 2006
Portfolio 65
| Date | Name | Website | Total Raised | Location |
| 22.08.2025 | KromaTiD™ ... | kromatid.com | $10M | United Sta... |
| 18.07.2024 | Hudson Rob... | hudsonrobotics.com | - | United Sta... |
| 27.04.2024 | CS Genetic... | csgenetics.com | - | United Kin... |
| 27.04.2024 | Fluidic An... | fluidic.com | $31M | United Kin... |
| 14.03.2024 | RoosterBio... | roosterbio.com | $36.75M | United Sta... |
| 26.10.2023 | PAK BioSol... | pakbiosolutions.com | - | United Sta... |
| 26.10.2023 | Pluristyx,... | pluristyx.com | - | United Sta... |
| 04.08.2023 | Nanocellec... | nanocellect.com | $46.8M | United Sta... |
| 23.04.2023 | Indee Labs | indeelabs.com | $5.9M | Australia,... |
| 30.01.2023 | PubGrade | pubgrade.com | - | Germany, N... |
Show more
Persons 8
| Date | First Name | Last Name | Title | Location | |||
| - | Daniel | Friedman | Principal | linkedin.c... | - | d*******n@... | - |
| - | Aaron | Goldman | Operating ... | linkedin.c... | - | a******n@x... | - |
| - | Austin | Duke | Managing D... | linkedin.c... | - | a***e@broa... | - |
| - | Royal | Donigan | Analyst | linkedin.c... | - | r******n@b... | - |
| - | Elliot | Frumkin | Director o... | linkedin.c... | - | e******n@b... | - |
| - | Trent | Carrier | Operating ... | linkedin.c... | - | t******r@b... | - |
| - | Max | Weis | Associate | linkedin.c... | - | m***s@broa... | - |
| - | Bill | Snider | Partner | linkedin.c... | - | b*****r@br... | - |
News 23
| Date | Title | Description |
| 23.01.2024 | ZoBio Sells to Oncodesign Services | BroadOak Capital Partners advised ZoBio on the sale of the company to Oncodesign Services. ZoBio is a leading provider of biophysics-based small molecule drug discovery services.. The full press release is below. Dijon, France & Leiden,... |
| 21.12.2023 | Pluristyx Closes Major Fundraising Round | BroadOak Capital Partners led Pluristyx’s latest fundraising round, which featured participation from existing investors and key opinion leaders in the life sciences sector. |
| 11.07.2023 | celares GmbH Sells to Biosynth | BroadOak Capital Partners advised Biosynth on the acquisition of celares GmbH. Celares provides customized bioconjugation solutions for Pharma and IVD industries. |
| 29.06.2023 | Genomenon Acquires Boston Genetics | Genomenon, a BroadOak portfolio company and a leader in genomic intelligence, acquired Boston Genetics, a genomics interpretation and curation company. |
| 12.04.2023 | Indee Labs Investment from BroadOak BioTools Venture Fund | BroadOak Capital Partners invested in Indee Labs out of its BioTools Venture Fund to support the development of Hydropore, which enables modified immune cell research and development with improved yield and function using a simple workflow,... |
| 09.01.2023 | BroadOak Invests in CDI Laboratories | BroadOak invested in CDI Labs, a provider of serological biomarker discovery services and monoclonal antibody manufacturing and validation services, to expand and scale antibody biomarker discovery platforms. |
| 09.01.2023 | Sanguine Biosciences Partners with BroadOak | Sanguine is a leader in custom specimen procurement used by biopharmaceutical companies to accelerate precision medicine and cell & gene therapy R&D. Our investment will help Sanguine expand laboratory operations, leukapheresis offe... |
| 09.01.2023 | PBS Biotech Raises $22M | BroadOak portfolio company PBS Biotech, an innovative manufacturer of single-use bioreactors, has completed a $22 million financing that will be used to improve the company’s products portfolio, expand its process development services capab... |
| 14.12.2022 | FujiFilm Invests in PhenoVista Biosciences | BroadOak portfolio company PhenoVista Biosciences, a leading provider of both custom and off-the-shelf imaging-based assay services, received an investment from Fujifilm’s Life Sciences Corporate Venture Capital Fund to accelerate developme... |
| 22.11.2022 | BioCare Medical Acquires Empire Genomics | BioCare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) and FISH (Fluorescent in situ hybridization) instrumentation and reagents, acquired BroadOak portfolio company Empire Genomics, a market leader in molec... |
Show more
Mentions in press and media 11
| Date | Title | Description |
| 14.11.2025 | BroadOak Capital Partners Announces New Investments Across Life Sciences Portfolio | BroadOak Capital Partners has announced a series of new growth investments that expand its life sciences platform and reinforce its position as a long-term partner to emerging industry leaders. The activity includes the first investment fro... |
| 29.10.2025 | BroadOak Capital Partners Adds $200 Million In Permanent Capital | BroadOak Capital Partners, a life sciences-focused investment and advisory firm, has secured more than $200 million in permanent capital, expanding its capacity to invest flexibly across the life sciences ecosystem. The new capital strength... |
| 16.10.2025 | Codis Receives Growth Capital | Codis, a St. Louis, Missouri-based CDMO focused on commercial spray drying, amorphous solid dispersions (ASD), particle engineering, and finished-dose manufacturing, received a growth investment from 1315 Capital, with participation from ex... |
| 22.08.2025 | KROMATID: $8 Million Series C Raised For Genomic Structural Analysis | KROMATID, a pioneering force in next-generation genomic structural analysis, announced the completion of its Series C funding round, which has raised a total of $8 million, significantly exceeding its initial capital goals. The latest tranc... |
| 28.07.2025 | Pluristyx Closes Investment Round | Pluristyx, a Seattle, WA-based provider of induced pluripotent stem cell (iPSC) technologies and proprietary gene editing solutions, closed its funding. The amount of the deal was not disclosed. The round was led by BioLife Solutions and Br... |
| 06.01.2025 | PBS Biotech: $17 Million In Growth Capital Raised | PBS Biotech – a provider of single-use bioreactor systems and bioprocess development services – announced it secured $17 million in follow-on growth capital from Avego Management and BroadOak Capital Partners. These funds will advance PBS’ ... |
| 22.06.2022 | Kemp Proteins Secures $5M Growth Financing from BroadOak Capital Partners | "Broadoak’s growth investment will enable us to acquire several S.I.P. fermenters, digitized controllers with off-site monitoring capabilities and additional lab space." - Michael Keefe, CEO Kemp Proteins FREDERICK, Md. (PRWEB) Ju... |
| 03.11.2021 | Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans - Form 8-K | Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans PARSIPPANY, NJ, November 2, 2021 (GLOBE NEWSWIRE) - Interpace Biosciences, Inc. ("Interpace" or the &quo... |
| 02.11.2021 | Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans | PARSIPPANY, NJ, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it, along with its subsidiaries, has entered into a new $8 million term loan with BroadOak Fund ... |
| 02.11.2021 | Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity Loans | PARSIPPANY, NJ, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it, along with its subsidiaries, has entered into a new $8 million term loan with BroadOak Fund ... |
Show more